South Asian Drugs And Addictions Research Council Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 6 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
About South Asian Drugs And Addictions Research Council
South Asian Drugs And Addictions Research Council (SADAARC) is a Private Not For Profit Company incorporated in India on 06 July 2018 (Six years and seven months 22 days old ). Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Surinder Singh and Kawal Kour serve as directors at the Company.
Company Details
- Location
Gurugram, Haryana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85200HR2018NPL074884
- Company No.
074884
- Company Classification
Private Not For Profit Company
- Incorporation Date
06 Jul 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at South Asian Drugs And Addictions Research Council?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surinder Singh  | Director | 06-Jul-2018 | Current |
| Kawal Kour | Director | 06-Jul-2018 | Current |
Financial Performance of South Asian Drugs And Addictions Research Council.
South Asian Drugs And Addictions Research Council, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of South Asian Drugs And Addictions Research Council?
Unlock access to South Asian Drugs And Addictions Research Council's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Albatross Aviations Private LimitedSurinder Singh and Kawal Kour are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at South Asian Drugs And Addictions Research Council?
Unlock and access historical data on people associated with South Asian Drugs And Addictions Research Council, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of South Asian Drugs And Addictions Research Council, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped South Asian Drugs And Addictions Research Council's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.